Lpl Financial LLC Arcellx, Inc. Transaction History
Lpl Financial LLC
- $246 Billion
- Q1 2025
A detailed history of Lpl Financial LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 9,554 shares of ACLX stock, worth $641,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,554
Previous 9,274
3.02%
Holding current value
$641,646
Previous $706,000
11.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ACLX
# of Institutions
214Shares Held
48.8MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$302 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$268 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$252 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$236 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$204 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.94B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...